Enveda

Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster.

Latest funding

$311M Series B+ · September 23, 2026

Total raised: $714M across 5 sourced rounds

Website: enveda.com.

X: @enveda · 2,647 followers.

LinkedIn: envedabio.

Categories: Health and bio Education.

Sectors: Artificial Intelligence (AI), Biotechnology, Life Science, Pharmaceutical, Therapeutics.

Stage: Series B+.

Based in: Boulder, United States.

Founded: 2019.

Total raised: $714M in 5 sourced rounds.

Last round: Sep 23, 2026 · 53 days ago.

Headcount: 251–500 employees.

On Recent Funding since: Sep 29, 2026.

Signals

X account@enveda · created Dec 6, 2020 (5 years old) · 2,647 followers

Website registeredJul 13, 2001 (25 years old)

About Enveda

Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organisms.

TIMELINE · MONEY RAISED

@enveda·Raised $714M in 5 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Date	Round	Amount	Lead	Source
Sep 23, 2026	Series B+	$311M	CCatalio	fiercebiotech.com
Sep 4, 2025	Series B+	$150M	PPremji Invest	fiercebiotech.com
Nov 21, 2024	Series B+	$130M	FFPV Ventures	fiercebiotech.com
Jun 14, 2024	Series B+	$55M	—	techcrunch.com
Dec 21, 2022	Series B+	$68M	DDimension	endpts.com

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/enveda (get a free API key).